Skip to main content

DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.

Citation
Tong, X., et al. “Ddb1-Mediated Cry1 Degradation Promotes Foxo1-Driven Gluconeogenesis In Liver.”. Diabetes, pp. 2571-2582.
Center University of Michigan
Author Xin Tong, Deqiang Zhang, Nicholas Charney, Ethan Jin, Kyle VanDommelen, Kenneth Stamper, Neil Gupta, Johnny Saldate, Lei Yin
Abstract

Targeted protein degradation through ubiquitination is an important step in the regulation of glucose metabolism. Here, we present evidence that the DDB1-CUL4A ubiquitin E3 ligase functions as a novel metabolic regulator that promotes FOXO1-driven hepatic gluconeogenesis. In vivo, hepatocyte-specific deletion leads to impaired hepatic gluconeogenesis in the mouse liver but protects mice from high-fat diet-induced hyperglycemia. Lack of downregulates FOXO1 protein expression and impairs FOXO1-driven gluconeogenic response. Mechanistically, we discovered that DDB1 enhances FOXO1 protein stability via degrading the circadian protein cryptochrome 1 (CRY1), a known target of DDB1 E3 ligase. In the depletion condition, insulin fails to reduce the nuclear FOXO1 abundance and suppress gluconeogenic gene expression. Chronic depletion of in the mouse liver not only increases FOXO1 protein but also enhances hepatic gluconeogenesis. Thus, we have identified the DDB1-mediated CRY1 degradation as an important target of insulin action on glucose homeostasis.

Year of Publication
2017
Journal
Diabetes
Volume
66
Issue
10
Number of Pages
2571-2582
Date Published
12/2017
ISSN Number
1939-327X
DOI
10.2337/db16-1600
Alternate Journal
Diabetes
PMID
28790135
PMCID
PMC5606320
Download citation